By improving the understanding of the functional aspects of EP3 and its regulated factors, we aim to evaluate its eligibility as a possible future target not only in breast cancer prevention and treatment but also in all other gynecological cancer entities. The gene discussed is PTGER3; the disease is female reproductive organ cancer.